Initiating treatment when tumors averaged approximately 100 mm3, pCRISPRi targeting ΔNp63 or SOX2 significantly slowed tumor progression and induced apoptosis (Figure 5 and Figure 6). This evidence concerns the gene SOX2 and neoplasm.